Gary Marks1, Lytt I Gardner, Charles E Rose, Anne Zinski, Richard D Moore, Susan Holman, Allan E Rodriguez, Meg Sullivan, Thomas P Giordano. 1. aDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia bDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama cDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland dState University of New York, Downstate Medical Center, Brooklyn, New York eDivision of Infectious Diseases, Miller School of Medicine, University of Miami, Florida fDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts gDepartment of Medicine, Baylor College of Medicine, and the Center for Innovations in Quality, Effectiveness and Safety, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
Abstract
OBJECTIVE: We examined HIV transmission potential of patients in care by analyzing the amount of person-time spent above a viral load threshold that increases risk for transmission. DESIGN: Observational cohort and supplemental data. METHODS: The cohort included HIV patients who received care at six HIV clinics in the United States, from 1 April 2009 to 31 March 2013, and had two or more viral load tests during this interval. Person-time (in days) above a viral load of 1500 copies/ml out of the total observation time was determined by inspecting consecutive pairs of viral load results and the time intervals between those pairs. The person-time rate ratios comparing demographic and clinical subgroups were estimated with Poisson regression. RESULTS: The cohort included 14 532 patients observed for a median of 1073 days with a median of nine viral load records. Ninety percent of the patients had been prescribed antiretroviral therapy. On average, viral load exceeded 1500 copies/ml during 23% of the patients' observation time (average of 84 days per year, per patient). Percentage of person-time above the threshold was higher among patients who had more than a fourth of their viral load pairs exceeding a 6-month interval (34% of observation time), patients not on antiretroviral therapy (58% of time), new/re-engaging patients (34% of time), patients 16-39 years of age (32% of time), and patients of black race (26% of time). CONCLUSION: HIV patients in care spent an average of nearly a quarter of their time with viral loads above 1500 copies/ml, higher among some subgroups, placing them at risk for potentially transmitting HIV to others.
OBJECTIVE: We examined HIV transmission potential of patients in care by analyzing the amount of person-time spent above a viral load threshold that increases risk for transmission. DESIGN: Observational cohort and supplemental data. METHODS: The cohort included HIV patients who received care at six HIV clinics in the United States, from 1 April 2009 to 31 March 2013, and had two or more viral load tests during this interval. Person-time (in days) above a viral load of 1500 copies/ml out of the total observation time was determined by inspecting consecutive pairs of viral load results and the time intervals between those pairs. The person-time rate ratios comparing demographic and clinical subgroups were estimated with Poisson regression. RESULTS: The cohort included 14 532 patients observed for a median of 1073 days with a median of nine viral load records. Ninety percent of the patients had been prescribed antiretroviral therapy. On average, viral load exceeded 1500 copies/ml during 23% of the patients' observation time (average of 84 days per year, per patient). Percentage of person-time above the threshold was higher among patients who had more than a fourth of their viral load pairs exceeding a 6-month interval (34% of observation time), patients not on antiretroviral therapy (58% of time), new/re-engaging patients (34% of time), patients 16-39 years of age (32% of time), and patients of black race (26% of time). CONCLUSION: HIV patients in care spent an average of nearly a quarter of their time with viral loads above 1500 copies/ml, higher among some subgroups, placing them at risk for potentially transmitting HIV to others.
Authors: Isaac C H Fung; Manoj Gambhir; Ard van Sighem; Frank de Wolf; Geoffrey P Garnett Journal: J Acquir Immune Defic Syndr Date: 2012-05-01 Impact factor: 3.731
Authors: T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray Journal: N Engl J Med Date: 2000-03-30 Impact factor: 91.245
Authors: Lytt I Gardner; Gary Marks; Jason A Craw; Tracey E Wilson; Mari-Lynn Drainoni; Richard D Moore; Michael J Mugavero; Allan E Rodriguez; Lucy A Bradley-Springer; Susan Holman; Jeanne C Keruly; Meg Sullivan; Paul R Skolnik; Faye Malitz; Lisa R Metsch; James L Raper; Thomas P Giordano Journal: Clin Infect Dis Date: 2012-07-24 Impact factor: 9.079
Authors: John M Murray; John J Zaunders; Kersten K Koelsch; Ven Natarajan; Yunden Badralmaa; Kristin McBride; Alexander Carrera; David A Cooper; Sean Emery; Anthony D Kelleher Journal: AIDS Res Hum Retroviruses Date: 2013-08-09 Impact factor: 2.205
Authors: Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Mary Clare Kennedy; Thomas H Kerr; Evan Wood; Jeannie A Shoveller; Julio S G Montaner; M-J S Milloy Journal: AIDS Date: 2018-05-15 Impact factor: 4.177
Authors: Suzanne M McCluskey; Yap Boum; Nicholas Musinguzi; Jessica E Haberer; Jeffrey N Martin; Peter W Hunt; Vincent C Marconi; David R Bangsberg; Mark J Siedner Journal: J Acquir Immune Defic Syndr Date: 2017-10-01 Impact factor: 3.731
Authors: Robert H Paul; Kyu S Cho; Patrick Luckett; Jeremy F Strain; Andrew C Belden; Jacob D Bolzenius; Jaimie Navid; Paola M Garcia-Egan; Sarah A Cooley; Julie K Wisch; Anna H Boerwinkle; Dimitre Tomov; Abel Obosi; Julie A Mannarino; Beau M Ances Journal: J Acquir Immune Defic Syndr Date: 2020-08-01 Impact factor: 3.731
Authors: Richard A Teran; Adam W Carrico; Keith J Horvath; Martin J Downing; Mary Ann Chiasson; Suzan M Walters; Sabina Hirshfield Journal: Arch Sex Behav Date: 2019-10-19
Authors: Matthew E Levy; Anne K Monroe; Michael A Horberg; Debra A Benator; Sherry Molock; Rupali K Doshi; Lindsey Powers Happ; Amanda D Castel Journal: J Acquir Immune Defic Syndr Date: 2019-11-01 Impact factor: 3.731
Authors: Preeti Pathela; Kelly Jamison; Sarah L Braunstein; Julia A Schillinger; Olga Tymejczyk; Denis Nash Journal: J Acquir Immune Defic Syndr Date: 2018-07-01 Impact factor: 3.731
Authors: Michael J Stirratt; Gary Marks; Christine O'Daniels; Edward R Cachay; Meg Sullivan; Michael J Mugavero; Shireesha Dhanireddy; Allan E Rodriguez; Thomas P Giordano Journal: Sex Transm Infect Date: 2017-11-02 Impact factor: 3.519
Authors: Jessie K Edwards; Stephen R Cole; H Irene Hall; W Christopher Mathews; Richard D Moore; Michael J Mugavero; Joseph J Eron Journal: AIDS Date: 2018-01-14 Impact factor: 4.177